Related Experiment Videos
Hepatitis C-HIV coinfection: current and future therapy
Jagdeep J Vyas1, Robert S Brown, Paul J Gaglio
1Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, NY, NY 10032, USA.
Expert Review of Anti-Infective Therapy
|October 16, 2004
Summary
Hepatitis C coinfection in HIV patients is common and worsening due to better HIV treatment. This review explores the complex interaction and treatment strategies for coinfected individuals.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) coinfection affects 15-70% of human immunodeficiency virus (HIV)-infected patients.
- Advances in HIV therapy have improved patient survival, leading to an increased incidence of HCV-related liver disease complications.
- The interplay between HIV and HCV is intricate, impacting disease progression and treatment responses.
Purpose of the Study:
- To review the pathobiology of HCV/HIV coinfection.
- To discuss the inter-relation between HCV and HIV in coinfected patients.
- To outline current and future treatment strategies for this population.
Main Methods:
- Literature review of pathobiology and clinical studies.
- Analysis of viral interactions and immune responses.
- Synthesis of current and emerging therapeutic approaches.
Main Results:
- HIV infection accelerates HCV natural history.
- HIV treatment can modulate immune responses, potentially worsening liver injury through immune reconstitution.
- Understanding these interactions is crucial for effective management.
Conclusions:
- HCV/HIV coinfection presents unique challenges due to complex viral interactions.
- Effective management requires consideration of both viral infections and their interplay.
- Future research should focus on optimizing treatment strategies for coinfected patients.